In recent years, significant progress has been made, culminating in the development of the Oxford R21 vaccine, which holds immense promise. However, despite this remarkable advancement in vaccinal ...

However, Kenya now finds itself lagging behind in adopting the R21/Matrix-M vaccine, a more cost-effective and scalable alternative to RTS,S, while neighboring countries forge ahead. The delay is ...